Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.44
-0.01 (-0.69%)
At close: Jul 03, 2025, 3:56 PM
1.46
1.33%
After-hours: Jul 03, 2025, 04:20 PM EDT
-0.69% (1D)
| Bid | 1.43 |
| Market Cap | 155.92M |
| Revenue (ttm) | 17.78M |
| Net Income (ttm) | -130.21M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -0.91 |
| Forward PE | -2.29 |
| Analyst | Buy |
| Ask | 1.46 |
| Volume | 402,410 |
| Avg. Volume (20D) | 962,886 |
| Open | 1.46 |
| Previous Close | 1.45 |
| Day's Range | 1.44 - 1.49 |
| 52-Week Range | 1.05 - 5.17 |
| Beta | 0.42 |
About ACRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Aclaris Therapeutics Inc. is scheduled to release its earnings on Aug 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.02%
Aclaris Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-2.65%
Aclaris shares are trading higher after the company announced FDA clearance of its IND application for a Phase 1A/1B trial of ATI-052.
